Mar 24, 2025 · 20m · tbpn
Jake Adler on Raising $3M to "Make Soldiers Heal Faster and Think Smarter".
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
Biotech founder Jake Adler discusses raising $3.25 million to transform military medicine through rapid wound-healing nanocomposites, brain-computer sleep interfaces, biodefense surveillance, and an agile commercialization model disrupting legacy defense procurement.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Jake forcefully dismisses academic military medicine, stating they do a terrible job translating benchtop science to combat.
Hardest push from the hosts ▶ 13:31 Questioning biotech credibility post-TheranosThe host directly confronts the guest with the Theranos precedent and the challenge of verifying bio claims compared to software.
Biggest teaching moment ▶ 1:43 The technical evolution of battlefield hemostaticsJake educates the host on how early zeolite-based QuikClot caused severe burns and why military doctrine had to redefine casualty care.
The host holds their own ▶ 2:56 Demonstrating knowledge of military pharmacological useThe host displays detailed domain context, citing long-haul F-35 deployment routes and specific military stimulant classes like Modafinil.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| The Evolution of Battlefield Wound Care and Rapid Healing | 4 | 6 | 1 | 1 | The host displays familiar context regarding military stimulant use and long-haul fighter pilot deployments. The guest extensively educates on the technical history of QuikClot zeolite burns, evolving prolonged-casualty doctrine, and non-pharmacological sleep modulation. | |
| Dual-Use Potential of Defense Biotechnology for Civilians | 4 | 5 | 3 | 1 | The host asks nuanced procurement questions about continuing resolutions and defense programs of record. The guest aggressively critiques the academic establishment for failing to translate benchtop research to the battlefield. | |
| Drawing from Sci-Fi and Converging Academic Research | 4 | 6 | 2 | 1 | The host brings up the biological weapons convention framework and potential adversary non-compliance. The guest breaks down the DoD's bias toward kinetic threats, pandemic vulnerabilities, and the asymmetrical threat of biological weapons. | |
| Theranos' Legacy, Rigorous Validation, and Self-Testing | 4 | 5 | 3 | 2 | The host presses on Theranos skepticism and the difficulty of verifying biotech compared to consumer software. The guest agrees and forcefully calls out current neuromodulation startups exploiting FDA wellness loopholes. | |
| Recruiting Pathfinders and Battling Entrenched Defense Interests | 3 | 6 | 2 | 1 | The host cites an eccentric Ethereum on-chain conspiracy regarding Chinese BCI soldier control. The guest grounds the topic in real geopolitical reality, explaining China's neural interface patent lead and technical spatial-temporal EEG limits. |